ZNF77 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.993000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.345000E-01
Normal-vs-Stage2
6.503800E-01
Normal-vs-Stage3
1.387400E-01
Normal-vs-Stage4
4.837000E-01
Stage1-vs-Stage2
5.030700E-04
Stage1-vs-Stage3
4.262300E-02
Stage1-vs-Stage4
5.631400E-01
Stage2-vs-Stage3
2.985600E-01
Stage2-vs-Stage4
7.332100E-02
Stage3-vs-Stage4
1.133370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.705600E-01
Normal-vs-AfricanAmerican
2.722400E-01
Normal-vs-Asian
1.419220E-01
Caucasian-vs-AfricanAmerican
4.344600E-01
Caucasian-vs-Asian
4.045800E-02
AfricanAmerican-vs-Asian
3.225600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.688000E-01
Normal-vs-Female
9.398400E-01
Male-vs-Female
7.583600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.795000E-01
Normal-vs-Age(41-60Yrs)
9.139400E-01
Normal-vs-Age(61-80Yrs)
8.372800E-01
Normal-vs-Age(81-100Yrs)
8.653600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.684200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.263600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.672200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.238400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.683000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.364600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.480800E-01
Normal-vs-Daily Drinker
3.927600E-01
Normal-vs-Weekly Drinker
7.931400E-01
Normal-vs-Occasional Drinker
8.768400E-01
Normal-vs-Social Drinker
7.823200E-01
Non Drinker-vs-Daily Drinker
9.183800E-01
Non Drinker-vs-Weekly Drinker
1.133960E-01
Non Drinker-vs-Occasional Drinker
8.312000E-02
Non Drinker-vs-Social Drinker
1.104800E-01
Daily Drinker-vs-Weekly Drinker
8.170300E-02
Daily Drinker-vs-Occasional Drinker
8.966500E-02
Daily Drinker-vs-Social Drinker
1.171970E-01
Weekly Drinker-vs-Occasional Drinker
8.054800E-01
Weekly Drinker-vs-Social Drinker
9.562600E-01
Occasional Drinker-vs-Social Drinker
7.617400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.786600E-01
Normal-vs-Grade 2
9.055200E-01
Normal-vs-Grade 3
8.976600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.227400E-01
Grade 1-vs-Grade 3
1.862620E-01
Grade 1-vs-Grade 4
9.786600E-01
Grade 2-vs-Grade 3
8.286600E-01
Grade 2-vs-Grade 4
9.055200E-01
Grade 3-vs-Grade 4
8.976600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.373000E-01
Normal-vs-NonDiabetic
8.397600E-01
Diabetic-vs-NonDiabetic
4.380400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.361600E-01
Normal-vs-NoPancreatitis
7.755200E-01
Pancreatitis-vs-NoPancreatitis
8.634200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.876400E-01
Normal-vs-N1
6.773000E-01
N0-vs-N1
3.421700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.127800E-01
Normal-vs-TP53-NonMutant
5.753000E-01
TP53-Mutant-vs-TP53-NonMutant
1.041000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
